Sagittarius Life Science (3205) — Cash Flow Reinvestment Rate

Latest as of September 2025: 143.42x

Sagittarius Life Science (3205) has a Cash Flow Reinvestment Rate of 143.42x as of September 2025, reinvesting NT$17.93 Million (capex NT$83.00K plus investments NT$17.84 Million) from operating cash flow of NT$125.00K. Explore 3205 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

143.42x

(Capex + Investments) / Operating CF

Total Reinvested

NT$17.93 Million

Capex + Investments

Operating Cash Flow

NT$125.00K

TWD

Capital Expenditures

NT$83.00K

TWD

Sagittarius Life Science Cash Flow Reinvestment Rate (2015–2016)

Historical reinvestment intensity for Sagittarius Life Science across 2 annual periods. Also explore balance sheet size of Sagittarius Life Science for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Sagittarius Life Science (2015–2016)

Year-by-year capital reinvestment analysis for Sagittarius Life Science. For live market cap and broader valuation context, see Sagittarius Life Science market capitalisation.

Year	Reinvestment Rate	Total Reinvested (TWD)	Operating CF	Capex	YoY Change
2016	0.29x	NT$104.28 Million	NT$360.37 Million	NT$19.76 Million	▲ +15.2%
2015	0.25x	NT$59.76 Million	NT$237.94 Million	NT$2.95 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow